Latest stories on BDRX
Biodexa Pharmaceuticals files to sell 220.42M ordinary shares for holders
The Fly24 · bearishgeneral
Biodexa Pharmaceuticals enters warrant exercise transaction for $2.3M gross proceeds; shares rise
Seeking Alpha28 · bearishgeneral
Biodexa Enters Into Warrant Exercise Transaction for $2.3 Million in Gross Proceeds
GlobeNewswire28 · bearishgeneral
Biodexa Enters Into Warrant Exercise Transaction for $2.3 Million in Gross Proceeds
Business Insider42 · neutralgeneral
BDRX Nearly Doubles Premarket; Biodexa Faces a Fourth-Quarter Funding Test
TechStock²52 · neutralgeneral
BDRX Stock Doubles to $1.30—but Biodexa Says It Needs More Cash in Q4
TechStock²42 · neutralgeneral
Biodexa Pharmaceuticals reports 1H results
Seeking Alpha50 · neutralgeneral
Interim results for the six months ended June 30, 2026
StockTitan50 · neutralgeneral
Interim results for the six months ended June 30, 2026
Business Insider50 · neutralgeneral
Biodexa recruits 87 of 168 subjects in Serenta Phase 3 eRapa polyposis trial
The Fly56 · neutralproduct/pr
Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP
Business Insider67 · bullishproduct/pr
Result of General Meeting
StockTitan50 · neutralgeneral
Result of General Meeting
Business Insider50 · neutralgeneral
Biodexa Initiates Support Activities for FAP Patients and Treatment Centers in France
Business Insider56 · neutralproduct/pr
Biodexa Pharmaceuticals Calls July 29 General Meeting to Overhaul Share Capital Structure
TipRanks50 · neutralgeneral
Result of Annual General Meeting | BDRX Stock News
StockTitan50 · neutralgeneral
Postponement and Re-scheduling of Annual General Meeting | BDRX Stock News
StockTitan50 · neutralgeneral